百褶裙过时了，仿制的香奈儿裙装正流行。
但你真的需要有人告诉你，在家里做饭比在饭店吃便宜吗，或告诉你仿制的比知名品牌便宜吗？
Do you really need someone to tell you that cooking at home is cheaper than going out, or that generics are cheaper than name brands?
他仿制的爵、觚、鼎等古彝器，工艺精，品位高，古趣盎然。
He imitated the Duke, Gu, Ding Yi and other ancient, process refined, high grade, full of ancient fun.
综上所述，以上趋势表明，2010年将是全球仿制药产业的转折点。
Taken together, these trends point to 2010 being a turning-point for the global generics business.
我们也当然不赞成采取任何行动，使仿制产品的竞争力下降。
And we certainly do not favour any initiative that reduces competition from generic products.
第二，仿制药生产商不断合并，每种药物的生产商通常只有一两个公司。
Second, generic drugmakers have merged, so a given drug is often made by just one or two companies.
在这些领域，许多厂商除生产供国内使用的医疗产品外，还大量出口，特别是出口仿制药。
And many have a high volume of exports in these sectors, especially for generic medicines, in addition to producing medical products for domestic use.
15年前，博柏利正处于危机时刻，因为他们标志性的格纹印花被廉价的仿制品牌到处模仿。
Fifteen years ago, Burberry was at crisis point as their signature check pattern was widely imitated by cheap, imitation brands.
你可能乐于买仿制皮革，然后你也许又想知道你花的钱买到的是什么。
You may be happy to buy imitation leather, and then again, you may wonder what you're getting for your money.
品牌面临的第二个挑战，来自于医药等行业的仿制商品制造商。
A second challenge to brands has come from generics manufacturers in industries such as pharmaceuticals.
中国的政策支持会更进一步降低仿制药的价格，这会给药品研发机构及国际非专利药公司带来深远影响。
Chinese policy will drive generic prices down still further, with far-reaching consequences for both R&D players and international generic companies.
在Barr对EliLilly 's Evista案中，仿制药方提出宾夕法尼亚州大学拥有优先专利权使得Lilly公司的专利要求无效。
In Barr's ongoing case against Eli Lilly's Evista, the generic firm argues that a prior patent held by the University of Pennsylvania invalidates Lilly's claims.
培养仿制药大品种是振兴民族制药企业的可行途径之一。
Developing our own generic drug superstars is one of the ways to vitalize our national pharmaceutical industry.
尽管中国具有增长潜力，但主要生产仿制药的国内企业，仍占据约四分之三的市场。
In spite of China's growth potential, local companies, which mainly produce generic drugs, still account for about three quarters of the market.
这一趋势也应改变大公司的态度，使仿制药不只是被看作是需要容忍或冒风险的有害之物，而更应该看作是能触发完全不同的商业模式的灵感。
This trend too should change attitudes at big firms, so that generics are not seen merely as pests to be tolerated or paid off, but rather as inspiration for a radically different business model.
但他也表示，这次他非常谨慎地看待新仿制药物的前景，因为生物技术药物很难仿制。
But he also said he was more cautious about the promise of generics this time, because biotech medicines were not easy to copy.
但他也表示，这次他非常谨慎地看待新仿制药物的前景，因为生物技术药物很难仿制。
But he also said he was more cautious about the promise of generics this time, because biotech medicines were not easy to copy.
应用推荐